Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?

Tarsus Pharmaceuticals (TARS) was a notable mover on above-average trading volume, but the recent pattern of earnings estimate revisions is unlikely to provide fresh near-term upside momentum. The setup suggests caution for continuation unless estimates stabilize or improve.

Analysis

Tarsus Pharmaceuticals (TARS) was a notable mover on above-average trading volume, but the recent pattern of earnings estimate revisions is unlikely to provide fresh near-term upside momentum. The setup suggests caution for continuation unless estimates stabilize or improve.